Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Leish-111f, a Recombinant Polyprotein Vaccine That Protects against Visceral Leishmaniasis by Elicitation of CD4<sup>+</sup>T Cells

3 Jul 2007

Abstract excerpt

The Leishmania-derived recombinant polyprotein Leish-111f or its three component proteins, thiol-specific antioxidant (TSA), Leishmania major stress-inducible protein 1 (LmSTI1), and Leishmania elongation initiation factor (LeIF), have previously been demonstrated to be efficacious against cutaneous or mucosal leishmaniasis in mice, nonhuman primates, and humans. In this study we demonstrate that Leish-111f is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Research on Leishmaniasis Studies
Share to Trypanosoma species research and implications

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17606603
DOI: 10.1128/iai.00394-07

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Leish-111f, a Recombinant Polyprotein Vaccine That Protects against Visceral Leishmaniasis by Elicitation of CD4<sup>+</sup>T CellsPMID 17606603Read ↗

Heterologous Immunization With Defined RNA and Subunit Vaccines Enhances T Cell Responses That Protect Against Leishmania donovaniSemantic proximity Read ↗

Protection against Cutaneous Leishmaniasis Induced by Recombinant Antigens in Murine and Nonhuman Primate Models of the Human DiseaseSemantic proximity Read ↗

Preclinical validation of a second generation leishmanization vaccine against vector transmitted fatal visceral leishmaniasisSemantic proximity Read ↗

Immunotherapeutic Potential of the Recombinant <em>Leishmania infantum</em> Eukaryotic Initiation Factor (LieIF) in Murine Experimental Models of LeishmaniasisSemantic proximity Read ↗

Modular Multiantigen T Cell Epitope–Enriched DNA Vaccine Against Human LeishmaniasisSemantic proximity Read ↗

<i>Leishmania</i>vaccines: progress and problemsSemantic proximity Read ↗

Designing of a new multi-epitope vaccine against Leishmania major using Leish-F1 epitopes: An In-silico studySemantic proximity Read ↗

Vaccine candidates, immuno-dominant antigens, and potent vaccine adjuvants for preventing cutaneous leishmaniasis: a sysSemantic proximity Read ↗

Recent developments in leishmaniasisSemantic proximity Read ↗

Leishmaniasis: Current Status of Vaccine DevelopmentSemantic proximity Read ↗

Vaccination with Heat-killed Leishmania Antigen or Recombinant Leishmanial Protein and CpG Oligodeoxynucleotides Induces Long-Term Memory CD4<b>+</b>and CD8<b>+</b>T Cell Responses and Protection Against <i>Leishmania major</i> InfectionSemantic proximity Read ↗

Centrin-deficient <i>Leishmania mexicana</i> confers protection against Old World visceral leishmaniasisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.